Cart
sales@molnova.com
OSU-03012
CAS No. 742112-33-0
OSU-03012( AR-12 | AR 12 | OSU 03012 )
Catalog No. M15834 CAS No. 742112-33-0
OSU-03012 (AR-12) is a novel potent, orally active 3-phosphoinositide-dependent kinase-1 (PDK-1) with IC50 of 5 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 28 | In Stock |
|
| 5MG | 42 | In Stock |
|
| 10MG | 71 | In Stock |
|
| 25MG | 131 | In Stock |
|
| 50MG | 249 | In Stock |
|
| 100MG | 330 | In Stock |
|
| 200MG | 429 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOSU-03012
-
NoteResearch use only, not for human use.
-
Brief DescriptionOSU-03012 (AR-12) is a novel potent, orally active 3-phosphoinositide-dependent kinase-1 (PDK-1) with IC50 of 5 uM.
-
DescriptionOSU-03012 (AR-12) is a novel potent, orally active 3-phosphoinositide-dependent kinase-1 (PDK-1) with IC50 of 5 uM; induces apoptosis in PC-3 cells at low microM range, causes Akt dephosphorylation and inhibition of p70 S6 kinase activity; displays cytotocixity against a panel of 60 cell lines with mean GI50 of 3 uM; decreases incidences of carcinoma and metastasis in transgenic mouse model of prostate cancer.Blood Cancer Phase 1 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsAR-12 | AR 12 | OSU 03012
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPDK
-
RecptorPDK1
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number742112-33-0
-
Formula Weight460.45
-
Molecular FormulaC26H19F3N4O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 9 mg/mL (19.5 mM); Ethanol: <1 mg/mL; Water: <1 mg/mL （ < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESNCC(=O)NC1=CC=C(C=C1)N1N=C(C=C1C1=CC2=C(C=C1)C1=CC=CC=C1C=C2)C(F)(F)F
-
Chemical Name2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl} acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Johnson AJ, et al. Blood. 2005 Mar 15;105(6):2504-9.
2. Tseng PH, et al. Blood. 2005 May 15;105(10):4021-7.
3. Zhu J, et al. Cancer Res. 2004 Jun 15;64(12):4309-18.
4. Baryawno N, et al. Cancer Res. 2010 Jan 1;70(1):266-76.
molnova catalog
related products
-
BX795
BX795 is a potent and relatively specific PDK1 inhibitor with IC50 of 6 nM; also inhibits TBK1 and IKKε with IC50 of 6 nM and 41 nM.
-
OSU-03012
OSU-03012 (AR-12) is a novel potent, orally active 3-phosphoinositide-dependent kinase-1 (PDK-1) with IC50 of 5 uM.
-
GSK2334470
GSK2334470 is a novel PDK1 inhibitor with IC50 of ~10 nM in a cell-free assay.
